Cell surface protein glycosylation in cancer

Proteomics

Volumn 14, Issue 4-5, 2014, Pages 525-546

  Christiansen, Maja N ^a   Chik, Jenny ^a   Lee, Ling ^a   Anugraham, Merrina ^a   Abrahams, Jodie L ^a   Packer, Nicolle H ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

Biomarkers; Cancer; Glycoproteomics; Glycosylation; Glycosyltransferases; Membrane proteins

Indexed keywords

CELL PROTEIN; CELL SURFACE PROTEIN; ENZYME; GLYCAN; GLYCOSYLTRANSFERASE; MANNOSE; FUCOSE; N ACETYLGLUCOSAMINE; SIALIC ACID DERIVATIVE;

BREAST CANCER; CELL CULTURE; CELL STRUCTURE; CELL SURFACE; COLON CANCER; FUCOSYLATION; HUMAN; LIVER CANCER; MELANOMA; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; REVIEW; SIALYLATION; SKIN CANCER; CANCER TISSUE; CARBOHYDRATE ANALYSIS; CARCINOGENESIS; COLORECTAL CANCER; CORE FUCOSYLATION; DISEASE ASSOCIATION; NEOPLASM; NONHUMAN; TERMINAL FUCOSYLATION; TUMOR CELL CULTURE;

BIOMARKERS; CANCER; GLYCOPROTEOMICS; GLYCOSYLATION; GLYCOSYLTRANSFERASES; MEMBRANE PROTEINS;

CELL MEMBRANE; GLUCANS; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896774734     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300387     Document Type: Review

References (214)

1. Varki, A., Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3, 97-130.
2. Potapenko, I. O., Haakensen, V. D., Luders, T., Helland, A. et al., Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression. Mol. Oncol. 2010, 4, 98-118.
3. Dube, D. H., Bertozzi, C. R., Glycans in cancer and inflammation [mdash] potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 2005, 4, 477-488.
4. Wei, T., Liu, Q., He, F., Zhu, W. et al., The role of N-acetylglucosaminyltransferases V in the malignancy of human hepatocellular carcinoma. Exp. Mol. Pathol. 2012, 93, 8-17.
5. Julien, S., Ivetic, A., Grigoriadis, A., QiZe, D. et al., Selectin ligand Sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Cancer Res. 2011, 71, 7683-7693.
6. Kim, Y.-S., Ahn, Y. H., Song, K. J., Kang, J. G. et al., Overexpression and β-1, 6-N-acetylglucosaminylation-initiated aberrant glycosylation of TIMP-1: a "double whammy" strategy in colon cancer progression. J. Biol. Chem. 2012, 287, 32467-32478.
7. Liu, J. J., Lin, B., Hao, Y. Y., Li, F. F. et al., Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway. Oncol. Rep. 2010, 23, 833-841.
8. Hoja-Lukowicz, D., Link-Lenczowski, P., Carpentieri, A., Amoresano, A. et al., L1CAM from human melanoma carries a novel type of N-glycan with Galbeta1-4Galbeta1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells. Glycoconj. J. 2013, 30, 205-225.
9. Jemal, A., Bray, F., Center, M. M., Ferlay, J. et al., Global cancer statistics. CA: Cancer J. Clin. 2011, 61, 69-90.
10. Herlyn, M., Fukunaga-Kalabis, M., What is a good model for melanoma? J. Invest. Dermatol. 2010, 130, 911-912.
11. Butler, M., Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by mammalian cell systems. Cytotechnology 2006, 50, 57-76.
12. Kao, J., Salari, K., Bocanegra, M., Choi, Y.-L. et al., Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 2009, 4, e6146.
13. Neve, R. M., Chin, K., Fridlyand, J., Yeh, J. et al., A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10, 515-527.
14. Lacroix, M., Leclercq, G., Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res. Treat 2004, 83, 249-289.
15. Yen, T.-Y., Macher, B. A., McDonald, C. A., Alleyne-Chin, C., Timpe, L. C., Glycoprotein profiles of human breast cells demonstrate a clear clustering of normal/benign versus malignant cell lines and basal versus luminal cell lines. J. Proteome Res. 2011, 11, 656-667.
16. Tao, S.-C., Li, Y., Zhou, J., Qian, J. et al., Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. Glycobiology 2008, 18, 761-769.
17. Gillet, J.-P., Varma, S., Gottesman, M. M., The clinical relevance of cancer cell lines. J. Natl. Cancer Inst. 2013, 105, 452-458.
18. Houshdaran, S., Hawley, S., Palmer, C., Campan, M. et al., DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines. PLoS One 2010, 5, e9359.
19. Tashiro, Y., Yonezawa, S., Kim, Y. S., Sato, E., Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. Hum. Pathol. 1994, 25, 364-372.
20. Ryuko, K., Iwanari, O., Kitao, M., Moriwaki, S., Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas. Gynecol. Oncol. 1993, 49, 215-224.
21. Dietel, M., Discrimination between benign, borderline, and malignant epithelial ovarian tumors using tumor markers: an immunohistochemical study. Cancer Detect. Prev. 1983, 6, 255-262.
22. Kobayashi, H., Terao, T., Kawashima, Y., Sialyl Tn as a prognostic marker in epithelial ovarian cancer. Br. J. Cancer 1992, 66, 984-985.
23. Davidson, B., Berner, A., Nesland, J. M., Risberg, B. et al., Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. Hum. Pathol. 2000, 31, 1081-1087.
24. Davidson, B., Gotlieb, W. H., Ben-Baruch, G., Kopolovic, J. et al., Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study. Gynecol. Oncol. 2000, 77, 35-43.
25. Zaia, J., Mass spectrometry and glycomics. OMICS 2010, 14, 401-418.
26. Wu, A. M., Lisowska, E., Duk, M., Yang, Z., Lectins as tools in glycoconjugate research. Glycoconj. J. 2009, 26, 899-913.
27. Handerson, T., Camp, R., Harigopal, M., Rimm, D., Pawelek, J., β1, 6-Branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma. Clin. Cancer Res. 2005, 11, 2969-2973.
28. Fernandes, B., Sagman, U., Auger, M., Demetrio, M., Dennis, J. W., β1-6 Branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res. 1991, 51, 718-723.
29. Cui, H., Lin, Y., Yue, L., Zhao, X., Liu, J., Differential expression of the alpha2, 3-sialic acid residues in breast cancer is associated with metastatic potential. Oncol. Rep. 2011, 25, 1365-1371.
30. Taeda, Y., Nose, M., Hiraizumi, S., Ohuchi, N., Expression of L-PHA-binding proteins in breast cancer: reconstitution and molecular characterization of beta 1-6 branched oligosaccharides in three-dimensional cell culture. Breast Cancer Res. Treat. 1996, 38, 313-324.
31. Fukasawa, T., Asao, T., Yamauchi, H., Ide, M. et al., Associated expression of alpha2, 3sialylated type 2 chain structures with lymph node metastasis in distal colorectal cancer. Surg. Today 2013, 43, 155-162.
32. Drake, P. M., Schilling, B., Niles, R. K., Prakobphol, A. et al., Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers. J. Proteome Res. 2012, 11, 2508-2520.
33. Abbott, K. L., Lim, J. M., Wells, L., Benigno, B. B. et al., Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis. Proteomics 2010, 10, 470-481.
34. Kremser, M. E., Przybylo, M., Hoja-Lukowicz, D., Pochec, E. et al., Characterisation of alpha3beta1 and alpha(v)beta3 integrin N-oligosaccharides in metastatic melanoma WM9 and WM239 cell lines. Biochim. Biophys. Acta 2008, 1780, 1421-1431.
35. Brooks, S. A., Hall, D. M. S., Buley, I., GalNAc glycoprotein expression by breast cell lines, primary breast cancer and normal breast epithelial membrane. Br. J. Cancer 2001, 85, 1014-1022.
36. Rambaruth, N. D. S., Greenwell, P., Dwek, M. V., The lectin Helix pomatia agglutinin recognises O-GlcNAc containing glycoproteins in human breast cancer. Glycobiology 2012, 22, 839-848.
37. Litynska, A., Przybylo, M., Pochec, E., Hoja-Lukowicz, D. et al., Comparison of the lectin-binding pattern in different human melanoma cell lines. Melanoma Res. 2001, 11, 205-212.
38. Laidler, P., Litynska, A., Hoja-Lukowicz, D., Labedz, M. et al., Characterization of glycosylation and adherent properties of melanoma cell lines. Cancer Immunol. Immunother. 2006, 55, 112-118.
39. Chen, S., Zheng, T., Shortreed, M. R., Alexander, C., Smith, L. M., Analysis of cell surface carbohydrate expression patterns in normal and tumorigenic human breast cell lines using lectin arrays. Anal. Chem. 2007, 79, 5698-5702.
40. Madjd, Z., Parsons, T., Watson, N., Spendlove, I. et al., High expression of Lewisy/b antigens is associated with decreased survival in lymph node negative breast carcinomas. Breast Cancer Res. 2005, 7, R780-R787.
41. Sakamoto, J., Furukawa, K., Cordon-Cardo, C., Yin, B. W. T. et al., Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res. 1986, 46, 1553-1561.
42. Itzkowitz, S. H., Yuan, M., Montgomery, C. K., Kjeldsen, T. et al., Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 1989, 49, 197-204.
43. Abbott, K. L., Aoki, K., Lim, J.-M., Porterfield, M. et al., Targeted glycoproteomic identification of biomarkers for human breast carcinoma. J. Proteome Res. 2008, 7, 1470-1480.
44. North, S. J., Huang, H.-H., Sundaram, S., Jang-Lee, J. et al., Glycomics profiling of Chinese hamster ovary cell glycosylation mutants reveals N-glycans of a novel size and complexity. J. Biol. Chem. 2010, 285, 5759-5775.
45. Balog, C. I. A., Stavenhagen, K., Fung, W. L. J., Koeleman, C. A. et al., N-glycosylation of colorectal cancer tissues. Mol. Cell. Proteomics 2012, 11, 571-585.
46. Kirmiz, C., Li, B., An, H. J., Clowers, B. H. et al., A serum glycomics approach to breast cancer biomarkers. Mol. Cel. Proteomics 2007, 6, 43-55.
47. Machado, E., Kandzia, S., Carilho, R., Altevogt, P. et al., N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin. Glycobiology 2011, 21, 376-386.
48. Robbe-Masselot, C., Herrmann, A., Maes, E., Carlstedt, I. et al., Expression of a core 3 disialyl-Le(x) hexasaccharide in human colorectal cancers: a potential marker of malignant transformation in colon. J. Proteome Res. 2009, 8, 702-711.
49. Larsson, J. M., Karlsson, H., Crespo, J. G., Johansson, M. E. et al., Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm. Bowel Dis. 2011, 17, 2299-2307.
50. Holmén Larsson, J. M., Karlsson, H., Sjövall, H., Hansson, G. C., A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. Glycobiology 2009, 19, 756-766.
51. Deshpande, N., Jensen, P. H., Packer, N. H., Kolarich, D., GlycoSpectrumScan: fishing glycopeptides from MS spectra of protease digests of human colostrum sIgA. J. Proteome Res. 2009, 9, 1063-1075.
52. Apte, A., Meitei, N., in: Li, J. (Ed.), Functional Glycomics, Humana Press 2010, pp. 269-281.
53. Abbott, K. L., Nairn, A. V., Hall, E. M., Horton, M. B. et al., Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer. Proteomics 2008, 8, 3210-3220.
54. Wang, P. H., Lee, W. L., Juang, C. M., Yang, Y. H. et al., Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecol. Oncol. 2005, 99, 631-639.
55. Hanski, C., Klussmann, E., Wang, J., Bohm, C. et al., Fucosyltransferase III and sialyl-Le(x) expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue. Glycoconj. J. 1996, 13, 727-733.
56. Ito, Y., Miyoshi, E., Sakon, M., Takeda, T. et al., Elevated expression of UDP-N-acetylglucosamine: αmannoside β1, 6 N-acetylglucosaminyltransferase is an early event in hepatocarcinogenesis. Int. J. Cancer 2001, 91, 631-637.
57. Kudo, T., Ikehara, Y., Togayachi, A., Morozumi, K. et al., Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab. Invest. 1998, 78, 797-811.
58. Trinchera, M., Malagolini, N., Chiricolo, M., Santini, D. et al., The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach. Int. J. Biochem. Cell Biol. 2011, 43, 130-139.
59. Yang, J. M., Byrd, J. C., Siddiki, B. B., Chung, Y. S. et al., Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology 1994, 4, 873-884.
60. Brockhausen, I., Yang, J. M., Burchell, J., Whitehouse, C., Taylor-Papadimitriou, J., Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur. J. Biochem. 1995, 233, 607-617.
61. Raval, G. N., Parekh, L. J., Patel, D. D., Jha, F. P. et al., Clinical usefulness of alterations in sialic acid, sialyl transferase and sialoproteins in breast cancer. Indian J. Clin. Biochem. 2004, 19, 60-71.
62. Julien, S., Krzewinski-Recchi, M. A., Harduin-Lepers, A., Gouyer, V. et al., Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2, 6-sialyltransferase (ST6GalNac I) cDNA. Glycoconj. J. 2001, 18, 883-893.
63. Lin, S., Kemmner, W., Grigull, S., Schlag, P. M., Cell Surface [alpha]2, 6-sialylation affects adhesion of breast carcinoma cells. Exp. Cell Res. 2002, 276, 101-110.
64. Kuan, S. F., Byrd, J. C., Basbaum, C. B., Kim, Y. S., Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res. 1987, 47, 5715-5724.
65. Perou, C., Sorlie, T., Eisen, M., Rijn, M. et al., Molecular portraits of human breast tumours. Nature 2000, 406, 747-752.
66. Dennis, J., Laferte, S., Waghorne, C., Breitman, M., Kerbel, R., Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987, 236, 582-585.
67. Vredenburgh, J. J., Simpson, W., Memoli, V. A., Ball, E. D., Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads. Cancer Res. 1991, 51, 2451-2455.
68. Imai, J., Ghazizadeh, M., Naito, Z., Asano, G., Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma. Anticancer Res. 2001, 21, 1327-1334.
69. Renkonen, J., Paavonen, T., Renkonen, R., Endothelial and epithelial expression of sialyl Lewisx and sialyl Lewisa in lesions of breast carcinoma. Int. J. Cancer 1997, 74, 296-300.
70. Kyselova, Z., Mechref, Y., Kang, P., Goetz, J. A. et al., Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin. Chem. 2008, 54, 1166-1175.
71. Dennis, J. W., Laferte, S., Oncodevelopmental expression of -GlcNAcβ1-6Manα1-6Manβ1- branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas. Cancer Res. 1989, 49, 945-950.
72. Burchell, J., Poulsom, R., Hanby, A., Whitehouse, C. et al., An alpha2, 3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology 1999, 9, 1307-1311.
73. Wu, C., Guo, X., Wang, W., Wang, Y. et al., N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry. BMC Cancer 2010, 10, 123.
74. Recchi, M. A., Hebbar, M., Hornez, L., Harduin-Lepers, A. et al., Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res. 1998, 58, 4066-4070.
75. Nakagoe, T., Fukushima, K., Itoyanagi, N., Ikuta, Y. et al., Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer. J. Cancer Res. Clin. Oncol. 2002, 128, 257-264.
76. Abd Hamid, U. M., Royle, L., Saldova, R., Radcliffe, C. M. et al., A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 2008, 18, 1105-1118.
77. Saldova, R., Reuben, J. M., Abd Hamid, U. M., Rudd, P. M., Cristofanilli, M., Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts. Ann. Oncol. 2011, 22, 1113-1119.
78. Alley, W. R., Madera, M., Mechref, Y., Novotny, M. V., Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. Anal. Chem. 2010, 82, 5095-5106.
79. de Leoz, M. L. A., Young, L. J. T., An, H. J., Kronewitter, S. R. et al., High-mannose glycans are elevated during breast cancer progression. Mol. Cell. Proteomics 2011, 10, M110.002717.
80. Listinsky, J. J., Siegal, G. P., Listinsky, C. M., The emerging importance of alpha-L-fucose in human breast cancer: a review. Am. J. Transl. Res. 2011, 3, 292-322.
81. Apweiler, R., Hermjakob, H., Sharon, N., On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1999, 1473, 4-8.
82. Misonou, Y., Shida, K., Korekane, H., Seki, Y. et al., Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells. J. Proteome Res. 2009, 8, 2990-3005.
83. Hundt, S., Haug, U., Brenner, H., Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1935-1953.
84. Bresalier, R. S., Ho, S. B., Schoeppner, H. L., Kim, Y. S. et al., Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 1996, 110, 1354-1367.
85. Malagolini, N., Santini, D., Chiricolo, M., Dall'Olio, F., Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. Glycobiology 2007, 17, 688-697.
86. Uemura, T., Shiozaki, K., Yamaguchi, K., Miyazaki, S. et al., Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4. Oncogene 2009, 28, 1218-1229.
87. Osumi, D., Takahashi, M., Miyoshi, E., Yokoe, S. et al., Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells. Cancer Sci. 2009, 100, 888-895.
88. Bu, X. D., Li, N., Tian, X. Q., Huang, P. L., Caco-2 and LS174T cell lines provide different models for studying mucin expression in colon cancer. Tissue Cell 2011, 43, 201-206.
89. Bresalier, R. S., Niv, Y., Byrd, J. C., Duh, Q. Y. et al., Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J. Clin. Invest. 1991, 87, 1037-1045.
90. Vavasseur, F., Dole, K., Yang, J., Matta, K. L. et al., O-Glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur. J. Biochem. 1994, 222, 415-424.
91. Ma, Y. C., Yang, J. Y., Yan, L. N., Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. Eur. J. Gastroenterol. Hepatol. 2013, 25, 1007-1016.
92. El-Serag, H. B., Rudolph, K. L., Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132, 2557-2576.
93. Hernandez-Gea, V., Turon, F., Berzigotti, A., Villanueva, A., Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension. World J. Gastroenterol. 2013, 19, 1193-1199.
94. Padhya, K. T., Marrero, J. A., Singal, A. G., Recent advances in the treatment of hepatocellular carcinoma. Curr. Opin. Gastroenterol. 2013, 29, 285-292.
95. Adamczyk, B., Tharmalingam, T., Rudd, P. M., Glycans as cancer biomarkers. Biochim. Biophys. Acta 2012, 1820, 1347-1353.
96. Oda, K., Ido, A., Tamai, T., Matsushita, M. et al., Highly sensitive lens culinaris agglutinin-reactive alpha-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. Oncol. Rep. 2011, 26, 1227-1233.
97. Moriya, S., Morimoto, M., Numata, K., Nozaki, A. et al., Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma. Anticancer Res. 2013, 33, 997-1001.
98. Taniguchi, N., Toward cancer biomarker discovery using the glycomics approach. Proteomics 2008, 8, 3205-3208.
99. Dai, Z., Zhou, J., Qiu, S. J., Liu, Y. K., Fan, J., Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers. Electrophoresis 2009, 30, 2957-2966.
100. Debruyne, E. N., Delanghe, J. R., Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin. Chim. Acta 2008, 395, 19-26.
101. Yamashiki, N., Seki, T., Wakabayashi, M., Nakagawa, T. et al., Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma. Oncol. Rep. 1999, 6, 1229-1232.
102. Kumada, T., Nakano, S., Takeda, I., Kiriyama, S. et al., Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. J. Hepatol. 1999, 30, 125-130.
103. Taketa, K., Endo, Y., Sekiya, C., Tanikawa, K. et al., A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 1993, 53, 5419-5423.
104. Li, D., Mallory, T., Satomura, S., AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin. Chim. Acta 2001, 313, 15-19.
105. Takada, A., Ohmori, K., Yoneda, T., Tsuyuoka, K. et al., Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 1993, 53, 354-361.
106. Dall'Olio, F., Chiricolo, M., D'Errico, A., Gruppioni, E. et al., Expression of β-galactoside α2, 6 sialyltransferase and of α2, 6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. Glycobiology 2004, 14, 39-49.
107. Mehta, A., Norton, P., Liang, H., Comunale, M. A. et al., Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue. Cancer Epidemiol. Biomarkers Prev. 2012, 21, 925-933.
108. Blomme, B., Van Steenkiste, C., Callewaert, N., Van Vlierberghe, H., Alteration of protein glycosylation in liver diseases. J. Hepatol. 2009, 50, 592-603.
109. Hutchinson, W. L., Du, M.-Q., Johnson, P. J., Williams, R., Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. Hepatology 1991, 13, 683-688.
110. Yao, M., Zhou, D.-P., Jiang, S.-M., Wang, Q.-H. et al., Elevated activity of N-acetylglucosaminyltransferase V in human hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 1998, 124, 27-30.
111. Passaniti, A., Hart, G. W., Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures. J. Biol. Chem. 1988, 263, 7591-7603.
112. Kawano, T., Takasaki, S., Tao, T. W., Kobata, A., N-linked sugar chains of mouse B16 melanoma cells and their low-metastasizing variant selected by wheat germ agglutinin. Glycobiology 1991, 1, 375-385.
113. Gorelik, E., Xu, F., Henion, T., Anaraki, F., Galili, U., Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose(alpha)1-2-galactose after alpha1, 2-fucosyltransferase cDNA transfection. Cancer Res. 1997, 57, 332-336.
114. Ochwat, D., Hoja-Lukowicz, D., Litynska, A., N-glycoproteins bearing beta1-6 branched oligosaccharides from the A375 human melanoma cell line analysed by tandem mass spectrometry. Melanoma Res. 2004, 14, 479-485.
115. Yoshimura, M., Ihara, Y., Matsuzawa, Y., Taniguchi, N., Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J. Biol. Chem. 1996, 271, 13811-13815.
116. Jemal, A., Siegel, R., Xu, J., Ward, E., Cancer statistics, 2010. CA. Cancer J. Clin. 2010, 60, 277-300.
117. Narod, S. A., Boyd, J., Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Curr. Opin. Obstet. Gynecol. 2002, 14, 19-26.
118. Alberts, D. S., Markman, M., Muggia, F., Ozols, R. F. et al., Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer. Gynecol. Oncol. 2006, 103, 783-792.
119. Fishman, D. A., Bozorgi, K., The scientific basis of early detection of epithelial ovarian cancer: the National Ovarian Cancer Early Detection Program (NOCEDP). Cancer Treat Res. 2002, 107, 3-28.
120. Ozols, R. F., Systemic therapy for ovarian cancer: current status and new treatments. Semin. Oncol. 2006, 33, S3-S11.
121. Vician, M., Hrbaty, B., Vrtik, L., Simo, J. et al., (Surgical treatment of acute diverticulitis of the large intestine). Rozhledy v. chirurgii: mesicnik Ceskoslovenske chirurgicke spolecnosti. 2000, 79, 275-278.
122. Crawford, S. C., Vasey, P. A., Paul, J., Hay, A. et al., Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial. J. Clin. Oncol. 2005, 23, 8802-8811.
123. Eltabbakh, G. H., Mount, S. L., Beatty, B., Simmons-Arnold, L. et al., Factors associated with cytoreducibility among women with ovarian carcinoma. Gynecol. Oncol. 2004, 95, 377-383.
124. Bhoola, S., Hoskins, W. J., Diagnosis and management of epithelial ovarian cancer. Obstet. Gynecol. 2006, 107, 1399-1410.
125. Friedlander, M., Buck, M., Wyld, D., Findlay, M. et al., Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer. Int. J. Gynecol. Cancer 2007, 17, 350-358.
126. Federici, M. F., Kudryashov, V., Saigo, P. E., Finstad, C. L., Lloyd, K. O., Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: serous and mucinous tumors exhibit distinctive patterns of expression. Int. J. Cancer 1999, 81, 193-198.
127. Jacob, F., Goldstein, D. R., Fink, D., Heinzelmann-Schwarz, V., Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs. Biomark. Med. 2009, 3, 743-756.
128. Annunziata, C. M., Azad, N., Dhamoon, A. S., Whiteley, G., Kohn, E. C., Ovarian cancer in the proteomics era. Int. J. Gynecol. Cancer 2008, 18 (Suppl 1), 1-6.
129. Nossov, V., Amneus, M., Su, F., Lang, J. et al., The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125? Am. J. Obstet. Gynecol. 2008, 199, 215-223.
130. Saldova, R., Dempsey, E., Perez-Garay, M., Marino, K. et al., 5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer. Epigenetics 2011, 6, 1362-1372.
131. Kui Wong, N., Easton, R. L., Panico, M., Sutton-Smith, M. et al., Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125. J. Biol. Chem. 2003, 278, 28619-28634.
132. Christie, D. R., Shaikh, F. M., Lucas, J. A. t., Lucas, J. A., 3rd, Bellis, S. L., ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J. Ovarian. Res. 2008, 1, 3. doi: 10.1186/1757-2215-1-3.
133. Yu, S. Y., Chang, L. Y., Cheng, C. W., Chou, C. C. et al., Priming mass spectrometry-based sulfoglycomic mapping for identification of terminal sulfated lacdiNAc glycotope. Glycoconj. J. 2013, 30, 183-194.
134. Escrevente, C., Machado, E., Brito, C., Reis, C. A. et al., Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines. Int. J. Oncol. 2006, 29, 557-566.
135. Satomaa, T., Heiskanen, A., Leonardsson, I., Angstrom, J. et al., Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. Cancer Res. 2009, 69, 5811-5819.
136. Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S. et al., Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am. J. Surg. Pathol. 2007, 31, 161-169.
137. Lee, Y., Miron, A., Drapkin, R., Nucci, M. R. et al., A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 2007, 211, 26-35.
138. Jarboe, E., Folkins, A., Nucci, M. R., Kindelberger, D. et al., Serous carcinogenesis in the fallopian tube: a descriptive classification. Int. J. Gynecol. Pathol. 2008, 27, 1-9.
139. Jacob, F., Goldstein, D. R., Bovin, N. V., Pochechueva, T. et al., Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. Int. J. Cancer. 2012, 130, 138-146.
140. Colombo, N., Peiretti, M., Parma, G., Lapresa, M. et al., Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2010, 21 (Suppl 5), v23-v30.
141. Wang, P. H., Altered glycosylation in cancer: sialic acids and sialyltransferases. J. Cancer Mol. 2005, 1, 73-81.
142. Varki, A., Schauer, R., Essentials of Glycobiology, Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY) 2009.
143. Tsuji, S., Molecular cloning and functional analysis of sialyltransferases. J. Biochem. 1996, 120, 1-13.
144. Ugorski, M., Laskowska, A., Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells. Acta Biochim. Pol. 2002, 49, 303-311.
145. Nakamori, S., Kameyama, M., Imaoka, S., Furukawa, H. et al., Increased expression of Sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and Immunohistochemical Study. Cancer Res. 1993, 53, 3632-3637.
146. Ravindranath, M. H., Amiri, A. A., Bauer, P. M., Kelley, M. C. et al., Endothelial-selectin ligands sialyl Lewis(x) and sialyl Lewis(a) are differentiation antigens immunogenic in human melanoma. Cancer 1997, 79, 1686-1697.
147. Renkonen, J., Paavonen, T., Renkonen, R., Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int. J. Cancer 1997, 74, 296-300.
148. Narita, T., Funahashi, H., Satoh, Y., Watanabe, T. et al., Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer. Cancer 1993, 71, 3044-3053.
149. Jeschke, U., Mylonas, I., Shabani, N., Kunert-Keil, C. et al., Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Anticancer Res. 2005, 25, 1615-1622.
150. Nakagoe, T., Fukushima, K., Nanashima, A., Sawai, T. et al., Expression of Lewis(a), sialyl Lewis(a), Lewis(x) and sialyl Lewis(x) antigens as prognostic factors in patients with colorectal cancer. Can. J. Gastroenterol. 2000, 14, 753-760.
151. Jagirdar, J., Thung, S. N., Shah, K. D., Nudelman, E. et al., Expression of sialylated Lewis(x) antigen in chronic and neoplastic liver diseases. Arch. Pathol. Lab. Med. 1992, 116, 643-648.
152. Ohyama, C., Tsuboi, S., Fukuda, M., Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. EMBO J. 1999, 18, 1516-1525.
153. Hebbar, M., Krzewinski-Recchi, M. A., Hornez, L., Verdiere, A. et al., Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients. Int. J. Biol. Markers 2003, 18, 116-122.
154. Dall'Olio, F., The sialyl-α2, 6-lactosaminyl-structure: Biosynthesis and functional role. Glycoconj. J. 2000, 17, 669-676.
155. Martersteck, C. M., Kedersha, N. L., Drapp, D. A., Tsui, T. G., Colley, K. J., Unique alpha 2, 8-polysialylated glycoproteins in breast cancer and leukemia cells. Glycobiology 1996, 6, 289-301.
156. Becker, D. J., Lowe, J. B., Fucose: biosynthesis and biological function in mammals. Glycobiology 2003, 13, 41R-53R.
157. Zhao, Y.-Y., Takahashi, M., Gu, J.-G., Miyoshi, E. et al., Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci. 2008, 99, 1304-1310.
158. Liu, Y.-C., Yen, H.-Y., Chen, C.-Y., Chen, C.-H. et al., Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc. Natl. Acad. Sci. 2011, 108, 11332-11337.
159. Alley, W. R., Jr., Vasseur, J. A., Goetz, J. A., Svoboda, M. et al., N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J. Proteome Res. 2012, 11, 2282-2300.
160. Miyoshi, E., Moriwaki, K., Nakagawa, T., Biological function of fucosylation in cancer biology. J. Biochem. 2008, 143, 725-729.
161. Ji, J., Gu, X., Fang, M., Zhao, Y. et al., Expression of alpha 1, 6-fucosyltransferase 8 in hepatitis B virus-related hepatocellular carcinoma influences tumour progression. Digest. Liver Dis. 2013, 45, 414-421.
162. Niv, Y., Byrd, J. C., Ho, S. B., Dahiya, R., Kim, Y. S., Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitro. Int. J. Cancer 1992, 50, 147-152.
163. Chen, T. R., Drabkowski, D., Hay, R. J., Macy, M., Peterson, W., Jr., WiDr is a derivative of another colon adenocarcinoma cell line, HT-29. Cancer Genet. Cytogenet. 1987, 27, 125-134.
164. Noguchi, P., Wallace, R., Johnson, J., Earley, E. M. et al., Characterization of WiDr: a human colon carcinoma cell line. In Vitro 1979, 15, 401-408.
165. Kawasaki, N., Lin, C. W., Inoue, R., Khoo, K. H. et al., Highly fucosylated N-glycan ligands for mannan-binding protein expressed specifically on CD26 (DPPVI) isolated from a human colorectal carcinoma cell line, SW1116. Glycobiology 2009, 19, 437-450.
166. Ferrara, C., Grau, S., Jäger, C., Sondermann, P. et al., Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose. Proc. Natl. Acad. Sci. 2011, 108, 12669-12674.
167. Miyoshi, E., Moriwaki, K., Nakagawa, T., Biological function of fucosylation in cancer biology. J. Biochem. 2008, 143, 725-729.
168. Kannagi, R., in: Taniguchi, N., Honke, K., Fukuda, M., Clausen, H., et al. (Eds.), Handbook of Glycosyltransferases and Related Genes, Springer, Japan 2002, pp. 237-245.
169. Matsuura, N., Narita, T., Hiraiwa, N., Hiraiwa, M. et al., Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewis(x), the carbohydrate ligands for E-selectin, in human breast cancer. Int. J. Oncol. 1998, 12, 1157-1164.
170. Ura, Y., Dion, A. S., Williams, C. J., Olsen, B. D. et al., Quantitative dot blot analyses of blood-group-related antigens in paired normal and malignant human breast tissues. Int. J. Cancer 1992, 50, 57-63.
171. Elola, M. T., Capurro, M. I., Barrio, M. M., Coombs, P. J. et al., Lewis x antigen mediates adhesion of human breast carcinoma cells to activated endothelium. Possible involvement of the endothelial scavenger receptor C-type lectin. Breast Cancer Res. Treat. 2007, 101, 161-174.
172. Yue, L., Yu, H., Zhang, C., Liu, J., The effect of overexpression of α1, 3-fucosyltransferase VII on adhesive capability of human colon carcinoma HT-29 cells to HUVECs. Adv. Mat. Res. 2012, 345, 250-256.
173. Basu, A., Murthy, U., Rodeck, U., Herlyn, M. et al., Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. Cancer Res. 1987, 47, 2531-2536.
174. Yin, B. W., Finstad, C. L., Kitamura, K., Federici, M. G. et al., Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer. Int. J. Cancer 1996, 65, 406-412.
175. Iwamori, M., Tanaka, K., Kubushiro, K., Lin, B. et al., Alterations in the glycolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the alpha1, 2-fucosyltransferase gene. Cancer Sci. 2005, 96, 26-30.
176. Guo, H.-B., Zhang, Y., Chen, H.-L., Relationship between metastasis-associated phenotypes and N-glycan structure of surface glycoproteins in human hepatocarcinoma cells. J. Cancer Res. Clin. Oncol. 2001, 127, 231-236.
177. Seberger, P. J., Chaney, W. G., Control of metastasis by Asn-linked, β1-6 branched oligosaccharides in mouse mammary cancer cells. Glycobiology 1999, 9, 235-241.
178. Guo, H. B., Randolph, M., Pierce, M., Inhibition of a specific N-glycosylation activity results in attenuation of breast carcinoma cell invasiveness-related phenotypes: inhibition of epidermal growth factor-induced dephosphorylation of focal adhesion kinase. J. Biol. Chem. 2007, 282, 22150-22162.
179. Guo, H.-B., Johnson, H., Randolph, M., Nagy, T. et al., Specific posttranslational modification regulates early events in mammary carcinoma formation. Proc. Natl. Acad. Sci. 2010, 107, 21116-21121.
180. Kim, Y. S., Hwang, S. Y., Kang, H. Y., Sohn, H. et al., Functional proteomics study reveals that N-Acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1. Mol. Cell. Proteomics 2008, 7, 1-14.
181. Przybylo, M., Martuszewska, D., Pochec, E., Hoja-Lukowicz, D., Litynska, A., Identification of proteins bearing beta1-6 branched N-glycans in human melanoma cell lines from different progression stages by tandem mass spectrometry analysis. Biochim. Biophys. Acta 2007, 1770, 1427-1435.
182. Ihara, S., Miyoshi, E., Nakahara, S., Sakiyama, H. et al., Addition of β1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin. Glycobiology 2004, 14, 139-146.
183. Guo, H.-B., Lee, I., Kamar, M., Akiyama, S. K., Pierce, M., Aberrant N-glycosylation of β1 integrin causes reduced α5β1 integrin clustering and stimulates cell migration. Cancer Res. 2002, 62, 6837-6845.
184. Siddiqui, S. F., Pawelek, J., Handerson, T., Lin, C. Y. et al., Coexpression of beta1, 6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 2517-2523.
185. Akama, R., Sato, Y., Kariya, Y., Isaji, T. et al., N-acetylglucosaminyltransferase III expression is regulated by cell-cell adhesion via the E-cadherin-catenin-actin complex. Proteomics 2008, 8, 3221-3228.
186. Ishibashi, K., Nishikawa, A., Hayashi, N., Kasahara, A. et al., N-Acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: Increased activity in liver cirrhosis and hepatoma patients. Clin. Chim. Acta 1989, 185, 325-332.
187. De Santis, G., Miotti, S., Mazzi, M., Canevari, S., Tomassetti, A., E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells. Oncogene 2009, 28, 1206-1217.
188. Lloyd, K. O., Burchell, J., Kudryashov, V., Yin, B. W., Taylor-Papadimitriou, J., Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem. 1996, 271, 33325-33334.
189. Lavrsen, K., Madsen, C. B., Rasch, M. G., Woetmann, A. et al., Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity. Glycoconj. J. 2013, 30, 227-236.
190. Soares, R., Marinho, A., Schmitt, F., Expression of sialyl-Tn in breast cancer. Correlation with prognostic parameters. Pathol. Res. Pract. 1996, 192, 1181-1186.
191. Campbell, B. J., Finnie, I. A., Hounsell, E. F., Rhodes, J. M., Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J. Clin. Invest. 1995, 95, 571-576.
192. Ogawa, H., Ghazizadeh, M., Araki, T., Tn and sialyl-Tn antigens as potential prognostic markers in human ovarian carcinoma. Gynecol. Obstet. Invest. 1996, 41, 278-283.
193. Inoue, M., Ton, S. M., Ogawa, H., Tanizawa, O., Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary. Am. J. Clin. Pathol. 1991, 96, 711-716.
194. Ohno, S., Ohno, Y., Nakada, H., Suzuki, N. et al., Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis. Anticancer Res. 2006, 26, 4047-4053.
195. Imada, T., Rino, Y., Hatori, S., Takahashi, M. et al., Sialyl Tn antigen expression is associated with the prognosis of patients with advanced colorectal cancer. Hepato-gastroenterology 1999, 46, 208-214.
196. Akamine, S., Nakagoe, T., Sawai, T., Tsuji, T. et al., Differences in prognosis of colorectal cancer patients based on the expression of sialyl Lewisa, sialyl Lewisx and sialyl Tn antigens in serum and tumor tissue. Anticancer Res. 2004, 24, 2541-2546.
197. Itzkowitz, S. H., Bloom, E. J., Kokal, W. A., Modin, G. et al., Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 1990, 66, 1960-1966.
198. Ohshio, G., Yoshioka, H., Manabe, T., Sakahara, H. et al., Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract. J. Cancer Res. Clin. Oncol. 1994, 120, 325-330.
199. Thor, A., Ohuchi, N., Szpak, C. A., Johnston, W. W., Schlom, J., Distribution of Oncofetal Antigen Tumor-associated Glycoprotein-72 Defined by Monoclonal Antibody B72.3. Cancer Res. 1986, 46, 3118-3124.
200. Carcel-Trullols, J., Stanley, J. S., Saha, R., Shaaf, S. et al., Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant. Int. J. Oncol. 2006, 28, 1173-1183.
201. Miles, D. W., Happerfield, L. C., Smith, P., Gillibrand, R. et al., Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer. Br. J. Cancer 1994, 70, 1272-1275.
202. Paschos, K. A., Canovas, D., Bird, N. C., The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell. Signal. 2009, 21, 665-674.
203. Bresalier, R. S., Byrd, J. C., Brodt, P., Ogata, S. et al., Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length. Int. J. Cancer 1998, 76, 556-562.
204. Ogata, S., Chen, A., Itzkowitz, S. H., Use of model cell lines to study the biosynthesis and biological role of cancer-associated sialosyl-Tn antigen. Cancer Res. 1994, 54, 4036-4044.
205. Cunningham, D., Atkin, W., Lenz, H.-J., Lynch, H. T. et al., Colorectal cancer. Lancet 2010, 375, 1030-1047.
206. Newsom-Davis, T. E., Wang, D., Steinman, L., Chen, P. F. et al., Enhanced immune recognition of cryptic glycan markers in human tumors. Cancer Res. 2009, 69, 2018-2025.
207. de Leoz, M. L., Young, L. J., An, H. J., Kronewitter, S. R. et al., High-mannose glycans are elevated during breast cancer progression. Mol. Cell. Proteomics 2011, 10, M110 002717.
208. Ulloa, F., Real, F. X., Differential distribution of sialic acid in α2, 3 and α2, 6 linkages in the apical membrane of cultured epithelial cells and tissues. J. Histochem. Cytochem. 2001, 49, 501-509.
209. Nakamori, S., Kameyama, M., Imaoka, S., Furukawa, H. et al., Involvement of carbohydrate antigen sialyl Lewis X in colorectal cancer metastasis. Dis. Colon Rectum 1997, 40, 420-431.
210. Nakamori, S., Kameyama, M., Imaoka, S., Furukawa, H. et al., Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and Immunohistochemical Study. Cancer Res. 1993, 53, 3632-3637.
211. Ogata, S., Koganty, R., Reddish, M., Michael Longenecker, B. et al., Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa. Glycoconj. J. 1998, 15, 29-35.
212. Ito, H., Hiraiwa, N., Sawada-Kasugai, M., Akamatsu, S. et al., Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. Int. J. Cancer 1997, 71, 556-564.
213. Petretti, T., Kemmner, W., Schulze, B., Schlag, P. M., Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 2000, 46, 359-366.
214. Lee, J. K., Matthews, R. T., Lim, J. M., Swanier, K. et al., Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V. J. Biol. Chem. 2012, 287, 28526-28536.